U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606872) titled 'Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes' on May 19.
Brief Summary: This study tests a new tool called the Snouda Metabolic Score (SMS) that helps doctors identify the specific metabolic problems driving Type 2 Diabetes in each individual patient. Instead of treating all diabetic patients the same way, the SMS classifies patients into one of several metabolic phenotypes - patterns of dysfunction across five body systems: insulin resistance, chronic inflammation, hormonal disruption, gut microbiome imbalance, and mitochondrial dysfunction.
Once classified, each participant follo...